[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

Meiragtx Holdings Plc (MGTX)

Meiragtx Holdings Plc (MGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Meiragtx Holdings Plc 655 THIRD AVENUE SUITE 1115 NEW YORK NY 10017 USA

www.meiragtx.com Employees: 403 P: 646-860-7985

Sector:

Medical

Description:

MeiraGTx Holdings plc focuses on operating as a holding company for MeiraGTx Limited which operates as a clinical stage gene therapy company. It develops novel gene therapy treatments for inherited and acquired disorders. The company's product pipeline consists of AAV-CNGB3, AAV-CNGA3, AAV-RPE65, AAV-RPGR, AAV-AQP1, AAV-AQP1 and AAV-UPF1 which are in clinical stage. MeiraGTx Holdings plc is based in New York.

Key Statistics

Overview:

Market Capitalization, $K 1,326,354
Enterprise Value, $K 1,310,114
Shares Outstanding, K 96,043
Float, K 88,936
% Float 92.60%
Short Interest, K 3,739
Short Float 3.89%
Days to Cover 8.07
Short Volume Ratio 0.41
% of Insider Shareholders 7.40%
% of Institutional Shareholders 67.48%

Financials:

Annual Sales, $ 81,390 K
Annual Net Income, $ -114,200 K
Last Quarter Sales, $ 321,430 K
Last Quarter Net Income, $ 160,720 K
EBIT, $ 184,030 K
EBITDA, $ 197,840 K

Growth:

1-Year Return 94.38%
3-Year Return 149.73%
5-Year Return 14.80%
5-Year Revenue Growth 423.07%
5-Year Earnings Growth 7.79%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 1.71 on 08/13/26
Next Earnings Date 11/12/26
Earnings Per Share ttm 0.71
EPS Growth vs. Prev Qtr 400.00%
EPS Growth vs. Prev Year 456.25%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

MGTX Ratios

Ratio
Price/Earnings ttm 19.46
Price/Earnings forward 46.45
Price/Earnings to Growth N/A
Return-on-Equity % 283.85%
Return-on-Assets % 29.39%
Profit Margin % -140.31%
Debt/Equity 0.46
Price/Sales 16.31
Price/Cash Flow N/A
Price/Book 5.93
Book Value/Share 2.33
Interest Coverage -8.36
60-Month Beta 1.23
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.